Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:ATCCode |
N05CM
|
| gptkbp:CASNumber |
500-64-1
|
| gptkbp:component |
kava extract
|
| gptkbp:discoveredIn |
1860
|
| gptkbp:drugClass |
benzodiazepine
sedative anticonvulsant |
| gptkbp:foundIn |
kava plant
|
| gptkbp:hasChEBI_ID |
CHEBI:6106
|
| gptkbp:hasMolecularFormula |
C14H14O3
|
| gptkbp:hasSMILES |
COC1=CC(=O)OC(C=CC2=CC=CC=C2)=C1
|
| gptkbp:hasUNII |
2U1W68TROF
|
| https://www.w3.org/2000/01/rdf-schema#label |
Kavain
|
| gptkbp:IUPACName |
4-methoxy-6-(2-phenylethyl)-2H-pyran-2-one
|
| gptkbp:legalStatus |
varies by country
|
| gptkbp:meltingPoint |
95–96 °C
|
| gptkbp:molecularWeight |
230.26 g/mol
|
| gptkbp:PubChem_CID |
5281603
|
| gptkbp:usedFor |
relaxation
treatment of anxiety |
| gptkbp:bfsParent |
gptkb:Kava
|
| gptkbp:bfsLayer |
6
|